|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
EBSCO_ocn829876061 |
| 003 |
OCoLC |
| 005 |
20231017213018.0 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
130312s2011 nyua ob 000 0 eng d |
| 040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d E7B
|d OCLCF
|d YDXCP
|d EBLCP
|d OCLCQ
|d D6H
|d VTS
|d TOF
|d AU@
|d STF
|d OCLCQ
|d K6U
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|
| 020 |
|
|
|a 9781612094953
|q (electronic bk.)
|
| 020 |
|
|
|a 1612094953
|q (electronic bk.)
|
| 020 |
|
|
|z 9781611227918
|
| 020 |
|
|
|z 1611227917
|
| 029 |
1 |
|
|a DEBBG
|b BV043774955
|
| 029 |
1 |
|
|a DEBSZ
|b 472773828
|
| 035 |
|
|
|a (OCoLC)829876061
|
| 050 |
|
4 |
|a R850
|b .A28 v.18eb
|
| 060 |
|
4 |
|a W 1
|
| 072 |
|
7 |
|a MED
|x 003040
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 009000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 029000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 048000
|2 bisacsh
|
| 072 |
|
7 |
|a TEC
|x 059000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 610.28
|2 23
|
| 049 |
|
|
|a UAMI
|
| 245 |
0 |
0 |
|a Advances in medicine and biology.
|n Volume 18 /
|c Leon V. Bernhardt, editor.
|
| 260 |
|
|
|a New York :
|b Nova Science Publishers,
|c ©2011.
|
| 300 |
|
|
|a 1 online resource :
|b illustrations
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a "Nova biomedical."
|
| 504 |
|
|
|a Includes bibliographical references.
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a ADVANCES IN MEDICINE AND BIOLOGY. VOLUME 18; ADVANCES IN MEDICINE AND BIOLOGY. VOLUME 18; CONTENTS; PREFACE; STUDY OF MYELOPROTECTIVE ACTIVITYOF PHARMACOLOGICAL AGENT NOVOGEN, UNDER CONDITIONS OF DURABLE INFLUENCEOF CHLORAMPHENICOL ON ORGANISM; INVESTIGATION MATERIALS AND METHODS; REFERENCES; ASSESSMENT OF SERUM ASCORBIC ACID LEVELSIN SOME SELECTED SURGICAL DISEASESAND IMPLICATIONS FOR WOUND HEALINGAND SURGERY- INDUCED OXIDATIVE STRESS; ABSTRACT; INTRODUCTION; PATIENTS AND METHODS; Patients and Study Design; Serum Sample Collection and Preparation; Assay for Serum Ascorbic Acid.
|
| 505 |
8 |
|
|a Statistical AnalysisEthics; RESULTS; DISCUSSION; REFERENCES; INDICATIONS AND MANAGEMENT OF M-TORINHIBITORS AFTER LIVER TRANSPLANTATION; ABSTRACT; INTRODUCTION; Objectives; MATERIAL AND METHODS; DEMOGRAPHIC CHARACTERISTICS; Data Analysis; RESULTS; Efficacy; Liver Graft Function after Conversion; Side Effects and Discontinuation; Pharmacokinetics; Patient Survival and Follow-Up; DISCUSSION; REFERENCES; LIVER TRANSPLANTATION: THERAPY; INTRODUCTION; ACUTE CELLULAR REJECTION; Allograft Recognition; T-Cell Activation; Clonal Expansion; Inflammation; IMMUNOSUPPRESSIVE AGENTS.
|
| 505 |
8 |
|
|a USE OF IMMUNOSUPPRESSIVE AGENTS IN LIVER TRANSPLANTATIONIN THE UNITED STATES. CALCINEURIN INHIBITORS-CYCLOSPORINE AND TACROLIMUS; Background; Mechanism of Action; Pharmacokinetics and Pharmacodynamics; Side Effects; Drug Interactions; Clinical use in Liver Transplantation; CORTICOSTEROIDS; Background; Mechanism of Action; Side Effects; Drug Interactions; Clinical use in Liver Transplantation; RAPAMYCIN; Background; Mechanism of Action; Pharmacokinetics and Pharmacodynamics; Side Effects; Drug Interactions; Clinical use in Liver Transplantation; PURINE SYNTHESIS INHIBITORS.
|
| 505 |
8 |
|
|a MYCOPHENOLATE MOFETILBackground; Mechanism of Action; Pharmacokinetics and Pharmacodynamics; Side Effects; Drug Interactions; Clinical use in Liver Transplantation; ANTILYMPHOCYTIC ANTIBODY THERAPY; MONOCLONAL ANTI-T- CELL RECEPTOR ANTIBODIES; Background/Discover; Mechanism of Action; Pharmcokinetics and Pharmocodynamics; Side Effects; Clinical use; POLYCLONAL ANTIBODIES; Background; Mechanism of Action; Pharmacokinetics and Pharmacodynamics; Side Effects; Clinical use; ALEMTUZUMAB/CAMPATH-1-H; INTERLEUKIN-2 RECEPTOR ANTIBODIES; Mechanism of Action; Pharmacokinetics and Pharmacodynamics.
|
| 505 |
8 |
|
|a Clinical useIMMUNOSUPPRESSANTS IN DEVELOPMENT; FK 778; JAK3 Inhibitors; FTY 720; BELATACEPT-COSTIMULATORY SIGNAL BLOCKADE; SUMMARY; REFERENCES; HISTOPATHOLOGICAL ANDIMMUNOHISTOCHEMICAL BACKGROUNDOF ORTHODONTIC TREATMENT; ABSTRACT; INTRODUCTION; DEVELOPING MANDIBULAR BODY BONE; DEVELOPING MANDIBULAR CARTILAGES; REGULATION FACTORS IN MORPHOGENESIS OF MANDIBULARCONDYLAR CARTILAGE; PERIODONTAL TISSUE REACTIONS IN ORTHODONTIC TREATMENT; PERIODONTAL TISSUE REACTION TO CELL INJURY STIMULATION; REFERENCES; REPERCUSSION OF MYTHS, BELIEFS AND PRACTICESON CHILDREN'S ORAL HEALTH; SUMMARY; INTRODUCTION.
|
| 590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
| 650 |
|
0 |
|a Medicine
|x Research.
|
| 650 |
|
6 |
|a Médecine
|x Recherche.
|
| 650 |
|
7 |
|a MEDICAL
|x Allied Health Services
|x Medical Technology.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Biotechnology.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Family & General Practice.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Lasers in Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a TECHNOLOGY & ENGINEERING
|x Biomedical.
|2 bisacsh
|
| 650 |
|
7 |
|a Medicine
|x Research
|2 fast
|
| 700 |
1 |
|
|a Berhardt, Leon V.
|
| 776 |
0 |
8 |
|i Print version:
|t Advances in medicine and biology. Volume 18.
|d New York : Nova Science Publishers, ©2011
|z 9781611227918
|w (OCoLC)785775614
|
| 856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=535073
|z Texto completo
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL3018928
|
| 938 |
|
|
|a ebrary
|b EBRY
|n ebr10662734
|
| 938 |
|
|
|a EBSCOhost
|b EBSC
|n 535073
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 10250770
|
| 994 |
|
|
|a 92
|b IZTAP
|
